Acute thromboembolic complications in patients with surgical pathology of abdominal cavity
DOI:
https://doi.org/10.11603/2414-4533.2016.4.7185Abstract
The incidence of acute thromboembolic complications (ATEC) is increasing annually and is equal to more than 100 cases per 100 000 people. In recent years ATEC came to occupy a leading position among postoperative ones through the introduction of new surgical technologies, improvement of surgery techniques, high level of modern anesthetics and intensive care, which resulted in lower mortality and reduced occurrence of specific postoperative complications. Despite the variety of proposed schemes by application of anticoagulants to prevent ATEC occurrence, their number requires a more detailed study of risk factors of ATEC and improvement of existing schemes for prevention and treatment of this pathology. The statistical retrospective analysis of outcomes of patients with acute surgical pathology of abdominal organs who were hospitalized in 2013–2015 were performed. According to this analysis the total number of patients with ATEC is 72 (0.43 %), the number of patients for whom the diagnosis was established during treatment is 34 (47.2 %), while pathoanatomical examination makes up 38 (52 8 %); PE in 51 patients proved to be the immediate cause of death, 21 patients cured with conservative methods in intensive care. In patients with urgent surgical pathology, especially cancer pathology, it is necessary to determine the risk factors, to appoint the prevention or treatment up to the standards (protocols) of medical care.
References
Arterialʹni, venozni trombozy ta tromboemboliyi. Profilaktyka ta likuvannya : naukove vydannya / vidp. za vyp. V. YU. Lishnevsʹka. – K. : ZAT “Vipol”, 2011. – 72 s.
Standarty orhanizatsiyi ta profesiyno oriyentovani protokoly nadannya medychnoyi dopomohy khvorym z nevidkladnoyu khirurhichnoyu patolohiyeyu orhaniv zhyvota / pa red. YA. S. Bereznytsʹkoho, P. D. Fomina. – K., 2010. – 470 s.
Randomized trial of the effect of the low molecular weight heparin nadroparin on survival in patients with cancer. / F. F. Doormaal, M. Di Nisio, H. M. Otten [et al.] // J. Clin. Oncol. – 2011. Vol. 29(15). – P. 2071–2076.
A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer / M. N. Levine, C. Gu, H. A. Liebman [et al.] // J. Thromb. Haemost. – 2012. – Vol. 10(5). – P. 807–814.
Prophylactic anti-coagulation in cancer palliative care: a prospective randomised study / C. Weber, T. Merminod, F. R. Herrmann, G. B. Zulian // Support Care Cancer. – 2008. – Vol. (7). – P. 847–852.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish their work in Hospital Surgery. Journal by L. Ya. Kovalchuk agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
